Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.
2.
3.

Neuroendocrine gastrointestinal tumours.

Oberg K.

Ann Oncol. 1996 Jul;7(5):453-63. Review.

4.

[Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].

Szczeblowska D.

Pol Merkur Lekarski. 2007 May;22(131):437-41. Review. Polish.

PMID:
17679390
5.
6.

State of the art and future prospects in the management of neuroendocrine tumors.

Oberg K.

Q J Nucl Med. 2000 Mar;44(1):3-12. Review.

PMID:
10932597
7.

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.

Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S, Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M.

Hepatogastroenterology. 2005 May-Jun;52(63):731-41.

PMID:
15966194
8.

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.

Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP.

Gastroenterology. 2010 Sep;139(3):742-53, 753.e1. doi: 10.1053/j.gastro.2010.07.002. Epub 2010 Jul 13. Review.

PMID:
20637207
9.

Molecular genetics of gastroenteropancreatic neuroendocrine tumors.

Starker LF, Carling T.

Curr Opin Oncol. 2009 Jan;21(1):29-33. doi: 10.1097/CCO.0b013e328319ea7b. Review.

PMID:
19125015
10.

Diagnosis and management of gastrointestinal neuroendocrine tumors.

Modlin IM, Basson MD, Mani S.

Gastroenterologist. 1993 Mar;1(1):59-70. Review.

PMID:
8049881
11.
12.

[The somatostatin receptor family--a window against new diagnosis and therapy of cancer].

Hofsli E.

Tidsskr Nor Laegeforen. 2002 Feb 20;122(5):487-91. Review. Norwegian.

PMID:
11961977
13.

Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.

Gibril F, Jensen RT.

Dig Liver Dis. 2004 Feb;36 Suppl 1:S106-20. Review.

PMID:
15077919
14.

Endocrine tumors of the gastrointestinal tract.

Haller DG.

Curr Opin Oncol. 1994 Jan;6(1):72-6. Review.

PMID:
8204694
15.

[Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].

Kos-Kudła B, Bolanowski M, Handkiewicz-Junak D, Jarzab B, Królicki L, Krzakowski M, Kunikowska J, Nasierowska-Guttmejer A, Nowak A, Rydzewska G, Starzyńska T, Szawłowski A; oraz Pozostali Uczestnicy Konferencji Okragłego Stołu.

Endokrynol Pol. 2008 Jan-Feb;59(1):41-56. Polish.

PMID:
18335400
16.

Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors.

Lubensky IA, Zhuang Z.

Endocr Pathol. 2007 Fall;18(3):156-62. Review.

PMID:
18041590
17.

Imaging of neuroendocrine tumors.

Rufini V, Calcagni ML, Baum RP.

Semin Nucl Med. 2006 Jul;36(3):228-47. Review.

PMID:
16762613
18.

New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.

Pape UF, Höcker M, Seuss U, Wiedenmann B.

Recent Results Cancer Res. 2000;153:45-60. Review.

PMID:
10626288
19.
20.

Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.

Turaga KK, Kvols LK.

CA Cancer J Clin. 2011 Mar-Apr;61(2):113-32. doi: 10.3322/caac.20097.

Items per page

Supplemental Content

Write to the Help Desk